GlobeImmune Cash Flow - Quarterly (OTCMKTS:GBIM)

Add to My Stocks
$0.51 $0.09 (15%) GBIM stock closing price Mar 19, 2018 (Closing)

The GlobeImmune cash flow statement helps investors understand how well the company is managing its cash flows. The profit-loss statement shows GlobeImmune profits, the balance sheet shows GlobeImmune debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. GlobeImmune cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. GlobeImmune had cash and cash equivalents of $- at the beginning of the quarter and $8.69M at quarter end for 2016 Q1. GlobeImmune has a negative cash and cash equivalents change of $-1.2M.

View and download details of GlobeImmune cash flows for latest & last 40 quarters
show more
Fiscal year is Jan - Dec2016 Q12015 Q42015 Q3
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow---
Net Increase (Decrease) in Assets Liabilities-0.38M-4.54M-3.89M
Cash From (used in) Discontinued Operations---
Other Adjustments Net--0.01M-0.02M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment---
Acquisition Disposition of Subsidiaires---
Increase (Decrease) in Investments---
Other Cash Inflow (Outflow) from Investment Activities---
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares---
Issuance (Repayment) of Debt Securities---
Increase (Decrease) in Bank & Other Borrowings---
Payment of Dividends & Other Cash Distributions---
Other Cash from (used by) Financing Activities---
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year---
Cash & Equivalents at Year End8.69M9.9M11.29M
All figures in USD. M: Millions of USD, B: Billions of USD.

GlobeImmune stock comparison chart provides an easy way to compare the stock price with peers along with details of GlobeImmune stock price history.
The statement of cash flows can be categorized into the following main sections:

  • GlobeImmune saw a positive change in Net Change in Cash and Cash Equivalents of $-1.2M till 2016 Q1. Apart from the GlobeImmune stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: GlobeImmune reported a negative operating cash flow of $-1.2M till 2016 Q1 and has seen an increase from the previous quarter. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $- for GBIM till last quarter 2016 Q1 report.
  • Cash flow from financing activities shows the flow of cash between GlobeImmune and its owners and creditors and was $- till 2016 Q1. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For GlobeImmune Cash Flow